Advanced search    

Search: authors:"Yuehu Wang"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Order-preservation of solution correspondence for parametric generalized variational inequalities on Banach lattices

In this paper, several order-theoretic fixed point theorems are proved on Banach lattices. As applications of these fixed point theorems, we study the order-preservation of solution correspondence for parametric generalized variational inequalities. Furthermore, the existence of solutions to equilibrium problems is also examined. Our approach is order-theoretic and all results...

Applications of order-theoretic fixed point theorems to discontinuous quasi-equilibrium problems

In this paper, we apply order-theoretic fixed point theorems and isotone selection theorems to study quasi-equilibrium problems. Some existence theorems of solutions to quasi-equilibrium problems are obtained on Hilbert lattices, chain-complete lattices and chain-complete posets, respectively. In contrast to many papers on equilibrium problems, our approach is order-theoretic and...

Wiener-Hopf equation technique for solving equilibrium problems and variational inequalities and fixed points of a nonexpansive mapping

In this paper, we introduce some new iterative schemes based on the Wiener-Hopf equation technique and auxiliary principle for finding common elements of the set of solutions of equilibrium problems, the set of fixed points of a nonexpansive mapping and the set of solutions of a variational inequality. Several strong convergence results for the sequences generated by these...

Acetylcholineestarase-Inhibiting Alkaloids from Lycoris radiata Delay Paralysis of Amyloid Beta-Expressing Transgenic C. elegans CL4176

The limited symptom relief and side effects of current Alzheimer’s disease (AD) medications warrant urgent discovery and study of new anti-AD agents. The “cholinergic hypothesis” of AD prompts us to search for plant-derived acetylcholineesterase (AChE) inhibitors such as galanthamine that has been licensed in Europe for AD treatment. We used the unique amyloid β-expressing...